Summary
Definição
História e exame físico
Principais fatores diagnósticos
- presencia de factores de riesgo
- erupción
- afectación de la mucosa
- signo de Nikolsky
- ampollas
Fatores de risco
- pacientes con cáncer activo
- medicamentos anticonvulsivos
- infección reciente
- uso reciente de antibióticos
- otros medicamentos
- lupus eritematoso sistémico
- Pacientes infectados por el VIH
- radioterapia
- antígeno leucocitario humano y predisposición genética
- vacunación contra la viruela
- trasplante de médula ósea
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- biopsia de piel
- hemocultivos
- hemograma completo
- glucosa
- magnesio
- fosfato
- urea
- bicarbonato
- electrolitos séricos
- creatinina sérica
- pruebas de función hepática
- velocidad de sedimentación globular
- proteína C-reactiva
- gasometría arterial y saturación de oxígeno
- radiografía de tórax
- estudios de coagulación
- hisopo de piel lesionada
- Serología de micoplasma
Investigações a serem consideradas
- inmunofluorescencia directa
Algoritmo de tratamento
todos los pacientes
Colaboradores
Autores
Areta Kowal-Vern, MD
Adjunct Research Faculty
Arizona Burn Center
Valleywise Health Medical Center
Phoenix
AZ
Declarações
AK-V performs occasional manuscript reviews on various topics for Research Square, Inc. and the Journal of Burn Care and Research in the US for which she receives a nominal monetary fee. AK-V is an author of a reference cited in this topic.
Revisores
Barbara A. Latenser, MD
Director Burn Unit
Department of Surgery
University of Iowa Hospitals
Iowa City
IA
Declarações
BAL declares that she has no competing interests.
Tina Palmieri, MD
Assistant Chief of Burns
Shriners Hospital
UC Davis
Sacramento
CA
Declarações
TP declares that she has no competing interests.
Venkat Gudi, MB BS
Consultant Dermatologist
Department of Dermatology
West Suffolk Hospital
Bury St. Edmunds
UK
Declarações
VG declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referências
Principais artigos
Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993 Jan;129(1):92-6. Resumo
Creamer D, Walsh SA, Dziewulski P, et al. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016. Br J Dermatol. 2016 Jun;174(6):1194-227.Texto completo Resumo
Seminario-Vidal L, Kroshinsky D, Malachowski SJ, et al. Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults. J Am Acad Dermatol. 2020 Jun;82(6):1553-67. Resumo
Gregory DG. New grading system and treatment guidelines for the acute ocular manifestations of Stevens-Johnson syndrome. Ophthalmology. 2016 Aug;123(8):1653-8. Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Erupción por fármacos con eosinofilia y síntomas sistémicos (DRESS)
- Dermatitis exfoliativa estafilocócica
- Síndrome de shock tóxico
Mais Diagnósticos diferenciaisDiretrizes
- Supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults
- Management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people (0 to 17 years)
Mais DiretrizesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal